VisionCare Opthalmic Expands Series E
Saratoga-based VisionCare Opthalmic Technologies has closed an expansion of the firm's Series E financing, the company said this week. The funding was led by Agate Medical Investments. Size of the round was not disclosed. As part of the funding, Chanan Schneider of Agate joins the company's board. VisionCare Opthalmic is developing visual prosthetic devices used to treat end-stage, age-related macular degeneration (AMD). In addition to Schneider, Pitango Venture CApital's David Israeli and Giza VEnture CApital's Yuval Avni have joined the firm's board, replacing Bruce E. Crocker and Elka Nir.
posted on Tuesday, January 24, 2012 (Link to more information)
Related companies:
VisionCare Opthalmic Technology
Related stories:
> VisionCare Ophthalmic Sees New Funding
> VisionCare Opthalmic Technologies Sees $15M
> VisionCare Ophthalmic Sees $31M More
> DigiSight Technologies Sees $7.8M In Series B
> Optovue Scores $10.5M
silicontap.com Home